Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PYCR1 | P32322 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13837013 | 0.96 | CA12 (0.36) | CA12CA1CA2CA4CA9 | |
| SCHEMBL104763 | 0.84 | PYCR1 (0.40) | CA12CA1CA2CA4CA9 | |
| SCHEMBL24046018 | 0.83 | CA12 (0.34) | CA12CA1CA2CA4CA9 | |
| SCHEMBL22082551 | 0.76 | CA12 (0.38) | CA12CA1CA2CA4CA9 | |
| SCHEMBL13259384 | 0.76 | KCNH2 (0.35) | CA12CA1CA2CA4CA9 | |
| SCHEMBL16465397 | 0.76 | CA12 (0.34) | CA12CA1CA2CA4CA9 | |
| SCHEMBL935039 | 0.76 | PYCR1 (0.38) | CA12CA2CA9ALDH1A1PYCR1 | |
| SCHEMBL13976980 | 0.75 | SAT1 (0.39) | — | |
| SCHEMBL16853285 | 0.74 | CA12 (0.33) | CA12CA1CA2CA4CA9 | |
| SCHEMBL17017116 | 0.74 | KCNH2 (0.34) | CA12CA1CA9PYCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3176457-A | — | — | None | — | — | JP | disclosed |
| CN-114195912-B | Preparation method and application of linear or cage-shaped supermolecule self-assembly ligand | 昆明理工大学 | 2022-09-27 | — | — | CN | disclosed |
| CN-114195912-A | Preparation method and application of linear or cage-shaped supermolecule self-assembly ligand | 昆明理工大学 | 2022-03-18 | — | — | CN | disclosed |
| US-20170216259-A1 | COMPOSITIONS AND METHODS FOR TARGETING RECEPTORS EXPRESSED IN THE GUT | SENSOR PHARMACEUTICALS, INC. | 2017-08-03 | — | — | US | disclosed |
| US-20170216259-A1 | COMPOSITIONS AND METHODS FOR TARGETING RECEPTORS EXPRESSED IN THE GUT | SENSOR PHARMACEUTICALS, INC. | 2017-08-03 | — | — | US | disclosed |
| US-20170216259-A1 | COMPOSITIONS AND METHODS FOR TARGETING RECEPTORS EXPRESSED IN THE GUT | SENSOR PHARMACEUTICALS, INC. | 2017-08-03 | — | — | US | disclosed |
| WO-2016014797-A1 | COMPOSITIONS AND METHODS FOR TARGETING RECEPTORS EXPRESSED IN THE GUT | SENSOR PHARMACEUTICALS, INC. (US) | 2016-01-28 | — | — | WO | disclosed |
| JP-H03176457-A | NOVEL PROPARGYL COMPOUND, ITS PRODUCTION AND COATING MATERIAL CONTAINING THE SAME COMPOUND | NIPPON PAINT CO LTD | 1991-07-31 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170216259-A1 | COMPOSITIONS AND METHODS FOR TARGETING RECEPTORS EXPRESSED IN THE GUT | FABP2, GPBAR1, NR1H4 | CA12 1453/4885CA1 2006/4885CA2 1729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.